David Michonneau

Multiplexed imaging of acute GVHD gastrointestinal biopsies revealed epithelial remodeling and alteration in immune composition, offering insight into disease pathology science.org/doi/10.1126/sc… @leeat_keren @WeizmannScience

Happy to share our last article in collaboration with @nofar_azulay and @leeat_keren @WeizmannScience in @ScienceTM A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiology science.org/doi/10.1126/sc…

Diet outperforms microbial transplant to drive microbiome recovery in mice | Nature nature.com/articles/s4158…

Great collaboration with Robert Zeiser ⁦@Uniklinik_Fr⁩ ⁦@Leukemia_Inst⁩ ⁦@univ_paris_cite⁩ Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey | Bone Marrow Transplantation nature.com/articles/s4140…

AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling ashpublications.org/bloodadvances/…

@SFGM_TC @APHP @HopSaintLouis @Leukemia_Inst @univ_paris_cite doi.org/10.1038/s41409…

Thanks to all collaborators, French centers of #alloHSCT and to @SFGM_TC. @APHP @HopSaintLouis @Leukemia_Inst @univ_paris_cite

Happy to share our last paper, published with @SpringerNature in @BMTjournal, about the French experience with belumosudil in the treatment of steroid-resistant cGvHD. Best ORR 57.4% including 14.7% of CR in patients who previously received at least 2 LOT rdcu.be/efZg9

CONGRESS | #EBMT25 | POSTER David Michonneau @MichonneauDavid, @HopSaintLouis @univ_paris_cite shares findings from a real-world retrospective analysis of belumosudil in treatment of #cGvHD. The results were consistent with the findings from the ROCKSTAR trial with no new safety signals identified. Follow our live feed for more updates: gvhdhub.com/medical-inform… #GvHD #MedicalCongress @TheEBMT

Celebrating an amazing colleague, mentor and friend Gerard Socie at the ASH meeting in San Diego

Thanks to our THEMA member @MichonneauDavid for presenting groundbreaking work on how an antibiotic can promote relapse by disrupting immune and metabolic networks #FirstTHEMALeukemiaSymposium

So happy to share the preprint of this wonderful collaboration with Keren’s lab @WeitzmanInst @leeat_keren to describe how immune cells are organized in gut during acute GvHD

📢 Program is out! Click here: lnkd.in/ejj8DsKD 📷 Next 09 and 10 september in Collège de France, Paris 💥Registration is free of charge @lane_andy @The_Ito_Lab @pvyas_oxford @DelwelRuud @LabPuissant @hi_stem_lab @MichonneauDavid @Nina_CabezasW @BenajibaLina & more!

Very interesting review on Graft versus leukemia and metabolism by @ApostolovaPetya and Ann-Cathrin Burk frontiersin.org/journals/immun…

How does #antiPD1 #therapy act in #lymphnodes to boost T cell responses ? New paper from the lab led by Mathilde Ruggiu and Marion Guérin with unexpected results (we think !) @ImmunoPasteur @institutpasteur @Inserm hubs.la/Q02myQw40 (1/6)

NEW: Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of @TheEBMT #bmtsm #GVHD thelancet.com/journals/lanha…

Cette année encore un immense merci à @DucatiMotor @DucatiFrance pour leur soutien et les cadeaux offerts aux patients greffés de moelle @HopSaintLouis @aphp. Nous avons été heureux de présenter le service à Maxime Loiseau directeur général de Ducati West Europe #MerryChristmas

[#Cancer] Découvrez le service hématologie greffe du Pr Peffault de Latour dédié à l'allogreffe de moelle @hopsaintlouis @APHP ! 👉 50 ans d'innovations 👉 140 allogreffes/an Des progrès porteurs d’espoir pour les patients atteints de maladies du sang youtube.com/watch?v=iXcvXc…

Definitively the most amazing #AdventCalendar2023